- Home
- Companies
- Viridos (formerly Synthetic Genomics, ...
- Products
- Predominant Production Platform for ...
Predominant Production Platform for Protein-based Therapeutics
Mammalian cell lines such as CHO are the predominant production platform for protein-based therapeutics. Despite four decades of use, this system presents challenges in terms of cost, quality, and efficacy. The industry is ripe for disruption. Drug developers, regulators, and reimbursement organizations are demanding faster and lower-cost methods to produce biologic medicines.
-
Most popular related searches
Customer reviews
No reviews were found for Predominant Production Platform for Protein-based Therapeutics. Be the first to review!